Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 2 3Phase 1/2 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Myeloid 1

Conditions

Leukemia, Myeloid, Acute 112Leukemia, Lymphocytic, Chronic, B-Cell 111Leukemia 102Myelodysplastic Syndromes 101Precursor Cell Lymphoblastic Leukemia-Lymphoma 80Lymphoma 77Lymphoma, Non-Hodgkin 73Multiple Myeloma 69Hodgkin Disease 67Lymphoma, Follicular 55Lymphoma, Mantle-Cell 52Leukemia, Myelogenous, Chronic, BCR-ABL Positive 51Myeloproliferative Disorders 50Congenital Abnormalities 47Lymphoma, Large B-Cell, Diffuse 46Lymphoma, B-Cell, Marginal Zone 45Leukemia, Myeloid, Accelerated Phase 43Leukemia, Myeloid, Chronic-Phase 42Burkitt Lymphoma 41Leukemia, Myelomonocytic, Chronic 40Blast Crisis 33Primary Myelofibrosis 32Lymphoma, Large-Cell, Immunoblastic 30Waldenstrom Macroglobulinemia 29Neoplasms, Plasma Cell 29Melanoma 29Anemia, Refractory, with Excess of Blasts 29Recurrence 27Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 25Myelodysplastic-Myeloproliferative Diseases 24

Interventions

blinatumomab 9Cyclophosphamide 7Rituximab 6Lenalidomide 6Dexamethasone 5Azacitidine 5venetoclax 4fludarabine 4Cytarabine 4fludarabine phosphate 3Maintenance 3Busulfan 3tislelizumab 2thymoglobulin 2pembrolizumab 2obinutuzumab 2daratumumab 2Whole-Body Irradiation 2N,N-dicyclohexyl-isoborneol-10-sulfonamide 2Methotrexate 2Melphalan 2Immunotherapy 2Imatinib Mesylate 2Drug Therapy 2Docetaxel 2Decitabine 2Clofarabine 2Cladribine 2Carboplatin 2Calcium Dobesilate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Neoplasm, Residual × fludarabine phosphate × Clear all
NCT06500273 2026-06-02

ALPHA3

Allogene Therapeutics

Phase 2 Recruiting
250 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse, Neoplasm, Residual

NCT02666898 2025-11-26

ICLL07GAI

French Innovative Leukemia Organisation

Phase 2 Completed
135 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasm, Residual

NCT01894477 2021-06-03

Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Fred Hutchinson Cancer Center

Phase 2 Unknown
102 enrolled 12 charts
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Neoplasm, Residual, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡